Topical Acne Treatment Update


Topical Acne Treatment

acne treatment

The #1 Best Selling Book "Acne Free in 3 Days" is the answer to your acne problems, whatever your age!

Heard it all before? Well, read dozens of real customer stories of how lives were delivered from acne misery.

WHY carry on suffering?
WHY let acne spoil your life?

Join the thousands whose lives have been transformed.
Just go straight to author Chris Gibson's page and check out the evidence - Click here for Chris.



More Acne Tips

acne blemishes laser treatment
treatment female adult acne
pictures baby acne
Acne prescriptions medications

We welcome you to Acne Treatment Center

"I will show you how I cured my acne condition in 3 days the natural way, saved myself from further scarring, and stopped wasting my money on expensive medications and over-the-counter products!"
....more

Updates on Topical Acne Treatment

Galderma Announces Availability of New Metrogel(R) 1% Pump Dispenser for the Treatment of Papulopustular Rosacea

FORT WORTH, TX-- - Galderma Laboratories, L.P. today announced the availability of a new pump dispenser design for MetroGel® Gel, 1%, the most powerful strength of topical metronidazole available in a ...

Read more...


Obagi® Medical Products Wins Best Skincare in the Second Annual NewBeauty Magazine Choice Awards

Obagi® Medical Products, Inc. , a leader in topical aesthetic and therapeutic skin health systems, has been recognized, for the second consecutive year, for having “The Best Skin-Care System at a Doctor’s Office” by NewBeauty Magazine.

Read more...


Ava MD, Now Offering New Photodynamic Cosmetic Treatment, Allumera®

Ava MD is thrilled to be offering Allumera as a new photodynamic cosmetic treatment that produces dynamic results for timeless skin and offers a new way for women & men to look their best at any age.Santa Monica, CA (PRWEB) January 05, 2012 Ava MD is thrilled to be offering Allumera as the first in a new class of photodynamic cosmetics. ...

Read more...


XOMA Initiates Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris

BERKELEY, Calif. -- XOMA Ltd. today announced it has begun dosing patients in its Phase 2 proof-of-concept study to evaluate the efficacy and safety of gevokizumab (XOMA 052), a potent inhibitor of interleukin-1 ...

Read more...


Natural brightening power

Here’s a highly effective yet gentle skin tone correcting product that can be used the whole year round.

Read more...


Blogsphere: technorati Technorati feedster Feedster bloglines Bloglines
Bookmark: delicious Del.icio.us spurl Spurl furl Furl simply Simpy blink Blink digg Digg